Table 1. IC50a Values (μM) of Synthetic Oridonin Nitrogen Mustard Derivatives (16a–f, 17a–c, and 18a–c) against Human Cancer Cell Linesb.
compd | K562 | MCF-7 | Bel-7402 | MGC-803 |
---|---|---|---|---|
oridonin | 4.76 ± 0.32 | 14.60 ± 1.21 | 7.48 ± 0.53 | 5.69 ± 0.37 |
chlorambucil | 60.12 ± 5.48 | 80.54 ± 4.73 | 49.31 ± 2.87 | 133.64 ± 11.25 |
melphalan | 33.37 ± 1.16 | 19.58 ± 1.02 | 24.76 ± 1.35 | 36.88 ± 1.21 |
benzoic acid mustard (15) | 142.67 ± 10.23 | 152.15 ± 8.66 | >200 | 146.20 ± 9.73 |
16a | 9.01 ± 0.78 | 14.37 ± 1.24 | 8.35 ± 0.74 | 9.30 ± 0.18 |
16b | 1.12 ± 0.07c | 0.68 ± 0.02c | 0.50 ± 0.01c | 1.09 ± 0.14c |
16c | 2.28 ± 0.69c | 1.32 ± 0.05c | 1.43 ± 0.09c | 2.02 ± 0.27c |
16d | 5.74 ± 0.45 | 12.90 ± 0.96 | 7.91 ± 0.85 | 6.92 ± 0.45 |
16e | 1.41 ± 0.10c | 3.22 ± 0.45c | 2.36 ± 0.67c | 6.72 ± 0.58 |
16f | 7.03 ± 0.34 | 14.58 ± 0.28 | 3.84 ± 0.32c | 7.10 ± 0.33 |
17a | 1.73 ± 0.09c | 3.63 ± 0.15c | 2.56 ± 0.51c | 4.71 ± 0.16 |
17b | 1.35 ± 0.12c | 0.91 ± 0.03c | 2.41 ± 0.23c | 3.76 ± 0.53c |
17c | 1.10 ± 0.15c | 0.79 ± 0.01c | 1.37 ± 0.06c | 2.25 ± 0.19c |
18a | 1.66 ± 0.22c | 2.88 ± 0.19c | 1.41 ± 0.11c | 3.39 ± 0.27c |
18b | 1.17 ± 0.14c | 0.67 ± 0.01c | 0.90 ± 0.03c | 1.60 ± 0.08c |
18c | 2.37 ± 0.19c | 2.25 ± 0.08c | 2.53 ± 0.47c | 3.95 ± 0.52c |
IC50: concentration that inhibits 50% of cell growth.
MTT method: drug exposure was for 72 h (means ± SD, n = 3).
*p < 0.001 vs oridonin group.